Information and Q&A session on updated CAPs in web-based eAF, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 May 2024, 10:00 (CEST) to 7 May 2024, 11:00 (CEST)

Training session on Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 October 2024, 10:00 (CEST) to 17 October 2024, 11:30 (CEST)

Info session on web-based electronic Application Form (eAF) add package, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 July 2024, 11:00 (CEST) to 18 July 2024, 12:00 (CEST)

EMEA-003476-PIP01-23

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2025, 11:00 (CEST) to 17 June 2025, 12:00 (CEST)

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva REOm, avian reovirus vaccine (inactivated), Status: Authorised

EMEA-003475-PIP01-23

Human medicines European public assessment report (EPAR): Kimmtrak, tebentafusp, Date of authorisation: 01/04/2022, Revision: 4, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Nervous system disorders, PIP number: P/0471/2023

EMEA-003498-PIP01-23